Tumor promoting role of anti-tumor macrophages in tumor microenvironment

KK Goswami, T Ghosh, S Ghosh, M Sarkar, A Bose… - Cellular …, 2017 - Elsevier
Recent advances in tumor biology demand detailed analysis of the complex interaction of
tumor cells with their adjacent microenvironment (tumor stroma) to understand the various …

The RTK interactome: overview and perspective on RTK heterointeractions

MD Paul, K Hristova - Chemical reviews, 2018 - ACS Publications
Receptor tyrosine kinases (RTKs) play important roles in cell growth, motility, differentiation,
and survival. These single-pass membrane proteins are grouped into subfamilies based on …

[HTML][HTML] Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis

S Braun, M Enculescu, ST Setty… - Nature …, 2018 - nature.com
Mutations causing aberrant splicing are frequently implicated in human diseases including
cancer. Here, we establish a high-throughput screen of randomly mutated minigenes to …

Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer

Y Zhou, X Xu, F Wang, H He, G Gong, L Xiong… - European Journal of …, 2020 - Elsevier
In this investigation, a novel series of quinoline analogues bearing thiazolidinones were
designed and synthesized based on our previous study. Among them, the most potent …

[HTML][HTML] Clinical potential of kinase inhibitors in combination with immune checkpoint inhibitors for the treatment of solid tumors

R Ahn, J Ursini-Siegel - International Journal of Molecular Sciences, 2021 - mdpi.com
Oncogenic kinases contribute to immunosuppression and modulate the tumor
microenvironment in solid tumors. Increasing evidence supports the fundamental role of …

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth

HA Ekiz, SCA Lai, H Gundlapalli, F Haroun… - …, 2018 - Taylor & Francis
The advent of immune checkpoint blockade as a new strategy for immunotherapy has
changed the outlook for many aggressive cancers. Although complete tumor eradication is …

Discovery of 4-((4-(4-(3-(2-(2, 6-difluorophenyl)-4-oxothiazolidin-3-yl) ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl) oxy)-N, N-diethylpiperidine-1-carboxamide as …

Y Zhou, X Xu, F Wang, H He, B Qi - Bioorganic Chemistry, 2021 - Elsevier
In this study, a novel series of 4, 6, 7-trisubstituted quinoline analogues bearing
thiazolidinones were designed and synthesized based on our previous study. Among them …

[HTML][HTML] mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential

N Faham, L Zhao, AL Welm - NPJ breast cancer, 2018 - nature.com
Metastasis is the biggest challenge in treating breast cancer, and it kills> 40,000 breast
cancer patients annually in the US. Aberrant expression of the RON receptor tyrosine kinase …

[HTML][HTML] Regulation of c-Raf Stability through the CTLH Complex

CJ McTavish, W Bérubé-Janzen, X Wang… - International journal of …, 2019 - mdpi.com
c-Raf is a central component of the extracellular signal-regulated kinase (ERK) pathway
which is implicated in the development of many cancer types. RanBPM (Ran-Binding …

Discovery of Novel, Thienopyridine-Based Tyrosine Kinase Inhibitors Targeting Tumorigenic RON Splice Variants

H Ryu, H Kim, I Park, M Lee, YS Park… - ACS Medicinal …, 2023 - ACS Publications
Herein, we report the identification, structural optimization, and biological efficacy of thieno
[2, 3-b] pyridines as potent inhibitors of splice variants of the tyrosine kinase recepteur …